The North America Single-use Bioprocessing Market would witness market growth of 15.4% CAGR during the forecast period (2022-2028).
Various bioprocessing techniques employ single-use media bags and containers. Additionally, single-use containers are frequently employed in the biopharmaceutical and biomanufacturing sectors for crucial liquid handling applications. Additionally, monoclonal antibodies (mAb) are produced using single-use bioprocessing technologies; as a result, this sector dominates the worldwide single-use bioprocessing market.
A small number of prospective medicines in the pipeline, the patent expiration of blockbuster molecules, and the rising demand for biologics have compelled businesses to adopt cutting-edge technologies like single-use bioprocessing methods, which are affordable and speed up the production process.
The cost of complex processes like sterilization, cleaning, as well as maintenance of steel-based bioreactor systems & accessories is decreased owing to the disposable equipment. Due to the substantial role that single-use bioprocessing systems play in lowering the initial investments and R&D costs associated with the manufacturing process of biologics, the demand for biopharmaceuticals is a major factor driving the growth of this market.
The United States is one of the nations with the biggest biopharmaceutical industry. With few market restrictions, the United States has one of the most hospitable domestic settings in the world for the research and commercialization of drugs. A science-based regulatory system that is regarded as the strictest in the world, the largest scientific research base supported by academic institutions and decades of government research funding, a strong intellectual property system that rewards innovation through patent and data protection, and robust capital markets are just a few of its advantages.
The US market dominated the North America Single-use Bioprocessing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $13,945.9 million by 2028. The Canada market is poised to grow at a CAGR of 18% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 17% during (2022 - 2028).
Based on Product, the market is segmented into Simple & Peripheral Elements (Tubing, Filters, Connectors, & Transfer Systems, Bags, Sampling Systems, Probes & Sensors [pH Sensor, Oxygen Sensor & Pressure Sensors, Temperature Sensors & Conductivity Sensors, Flow Sensors, and Others], and Others), Apparatus & Plants (Mixing, Storage, & Filling Systems, Bioreactors & Filtration System, Chromatography Systems & Pumps, and Others), and Work Equipment. Based on End-Use, the market is segmented into Biopharmaceutical Manufacturers and Academic & Clinical Research Institutes. Based on Workflow, the market is segmented into Upstream Bioprocessing, Fermentation, and Downstream Bioprocessing. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Single-use Bioprocessing Market is Estimated to reach $53.8 Billion by 2028, at a CAGR of 16%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Boehringer Ingelheim International GmbH, Corning Incorporated, Danaher Corporation, Eppendorf SE, Merck Millipore (Merck KGaA), Entegris, Inc., Sartorius Stedim Biotech S.A. (Sartorius AG), Thermo Fisher Scientific, Inc., and Avantor, Inc.
By Product
By End-use
By Workflow
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
